Study to Evaluate the Efficacy, Safety and Tolerability of Photodynamic Therapy(PDT) With Chlorin-e6 in Treating Moderate to Severe Acne

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-50
SponsorXiyuan Hospital of China Academy of Chinese Medical Sciences

About this trial

This study aims to evaluate the clinical efficacy, safety and tolerability of a photodynamic therapy(PDT) based on a new photosensitizer, Chlorin-e6, in the treatment of moderate to severe acne. The hypothesis is that the therapy has good efficacy, safety and tolerability.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Subject is male or non-pregnant female 18 years of age and younger than 50 years of age.

Subject has moderate to severe facial acne vulgaris.

Subject has provided written informed consent.

Disqualifiers

People who are taking photosensitive drugs;

Allergic to any component of the photosensitizer;

porphyrins or allergies to porphyrins, with a history of photosensitivity;

Pregnant or lactating women and those planning to become pregnant within 3 months;

Trial design

Design model

Parallel

Treatments tested in this trial

  • N-chlorin e6 triglumine

    Drug

    a photodynamic therapy with chlorin-e6

  • acne removal surgery

    Procedure/Surgery

    acne removal surgery will be given before red light exposure

Treatment groups

46 Participants
are divided into 2 treatment groups
Group A: photosensitizer groupExperimental treatment 2 interventions
Group B: photosensitizer-placebo groupPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in Global Acne Grading System (GAGS) Relative to Baseline

The Global Acne Grading System (GAGS) uses the grading score multiplied by the weight of the position, and the cumulative score is 1-18 for mild, 19-30 for moderate, 31-38 for severe, and above 39 for extremely severe.

Time frame
Baseline and 2 weeks/1 month/2 month/6 month after final treatment

Secondary outcomes

Other outcomes

1

Change in Inflammatory&non-inflammatory Lesion Counts Relative to Baseline

Acne, pimple, pustules, and nodules are classified as non-inflammatory and inflammatory in order to evaluate the efficacy of photodynamic anti-inflammatory.

Time frame
Baseline and 2 weeks/1 month/2 month/6 month after final treatment
2

Change in Acne-specific Quality of Life Assessment Instrument(Qol-Acne)Relative to Baseline

Self-perception, social functioning, and emotional functioning were recorded for the most recent week, with a score of 0-3 depending on the choice, with higher scores indicating worse impact of acne on quality of life.

Time frame
Baseline and 2 weeks/1 month/2 month/6 month after final treatment
3

Change in Numerical Rating Scale(NRS) Relative to Baseline

The NRS pain score is the digital pain score, which is used to assess the pain degree of the patient using the Digital Evaluation Scale of Pain Degree. The pain can be divided into different degrees according to the corresponding number, that is, 0 is no pain, 1-3 is mild pain, 4-6 is moderate pain, and 7-10 is severe pain. The higher the score, the higher the pain level and the greater the photodynamic side effects.

Time frame
5 minutes after the start of red light exposure and Immediately after the treatment
4

Number of participants with abnormalities of Hematological Parameters and Urine Parameters Relative to Baseline

white blood cell count,red blood cell count,haemoglobin,platelet count,ALT,AST,Cr andwhite blood cell count,red blood cell count,Protein in the urine. Clinical Complete blood cell analysis,Liver function,kidney function test and Clinical Urinalysiswill be used as the measurement tools of this result.Normal physiological parameters are regarded as the standard. If CREA is higher than normal after PDT or Protein in the urine is higher than normal, renal function may be impaired.If ALT or AST is higher than normal after PDT, liver function may be impaired.If the WBC is higher than normal after PDT, a systemic infection may be present.If RBC or Hb is lower than normal after PDT, anemia may be present.If PLT is lower than normal after PDT, a coagulopathy may be present.If WBC in the urine is higher than normal after PDT, a urinary tract infection may be present.If RBC in the urine is higher than normal after PDT, urological disorders may be present or coagulopathy may be present.

Time frame
Baseline and 2 weeks after final treatment

Sponsors and contacts

Click on the lead sponsor to view all of their trials.